Clarivate Plc (CLVT), a company providing transformative intelligence, Tuesday announced that it has unveiled the launch of DRG Fusion, a cutting-edge platform designed to enhance commercial analytics in the life sciences sector.
Built by clinical and data science experts, Fusion integrates real-world data to offer biopharma and medtech organizations powerful tools to navigate complex disease and competitive landscapes, streamlining the management of raw data.
DRG Fusion addresses these challenges by offering a comprehensive suite of market data and analytics derived from integrated medical and pharmacy claims, along with other real-world data sources. This enables life sciences organizations to better understand market dynamics and make informed decisions to drive innovation.
By providing actionable insights, the platform empowers life science organizations to create a healthier tomorrow, accelerating progress in the industry.
CLVT is currently trading at $5.01 down 2.15 percent or $0.11 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.